Year,Date,FillingDate,NetIncome,Revenue,OperatingIncome,EPSDiluted,GrossProfit,GrossProfitRatio,TotalAssets,CommonStockEquity,CurrentAssets,CurrentLiability,TotalLiability,Inventory,RetainedEarnings,EnterpriseValue,bookValuePerShare,currentRatio,debtToAssets,debtToEquity,roic,shareholdersEquityPerShare,roe,priceToSalesRatio,peRatio,pbRatio,payoutRatio,inventoryTurnover,dividendYield,assetTurnover,quickRatio,returnOnAssets,priceToFreeCashFlowsRatio,grossProfitMargin,epsdilutedGrowth,fiveYNetIncomeGrowthPerShare,fiveYRevenueGrowthPerShare,fiveYShareholdersEquityGrowthPerShare,grossProfitGrowth,netIncomeGrowth,operatingIncomeGrowth,threeYNetIncomeGrowthPerShare,threeYRevenueGrowthPerShare,threeYShareholdersEquityGrowthPerShare,Industry,Sector,Price,MarketCap,AvgVolume,Symbol
2022,2022-12-31,2023-03-20,-64506051.0,0.0,-65061417.0,-2.2,0.0,0.0,76843301.0,48898296.0,76511332.0,7665446.0,8076603.0,0.0,-80650212.0,269071159.5,1.665396550356518,9.981328157552737,0.0036773537357537517,0.00577893348267187,-1.3160850868090705,1.665396550356518,-1.3191881164938755,0.0,-4.779306773871493,6.304804701169955,0.0,0.0,0.0,0.0,9.436093346688503,-0.8394492448990446,-5.514124633971413,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Biotechnology,Healthcare,48.27,2493362715,730581,MLTX
2021,,,,,,,,,9682454.0,-11645007.0,9636715.0,21087601.0,21327461.0,0.0,-53643615.0,6961155.0,0.0,0.4569848888927669,1.5491940369662485,-1.2881057091678862,,0.0,,0.0,0.0,0.0,0.0,0.0,,,0.38826697261580395,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,Biotechnology,Healthcare,48.27,2493362715,730581,MLTX
TTM,,,,,,,,,,,,,,,,2443479772.0,1.0751928915425863,9.1359627112893,0.0036866126813613685,0.005863307742345323,-1.4612636870969193,1.0751928915425863,-1.1606063924793109,0.0,-30.988987009986413,44.89427002325761,0.0,0.0,0.0,0.0,8.713420240500096,-0.9108950831925096,-49.13187589544744,0.0,,,,,,,,,,,Biotechnology,Healthcare,48.27,2493362715,730581,MLTX
